PMC:7275137 / 5286-5481
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":95,"end":111},"obj":"Disease"},{"id":"T13","span":{"begin":159,"end":183},"obj":"Disease"},{"id":"T14","span":{"begin":185,"end":193},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"However, short-term inhibition of endocytosis could be a viable strategy for the management of viral infections with no alternative treatment options, such as coronavirus disease 2019 (COVID-19)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T37","span":{"begin":55,"end":56},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"However, short-term inhibition of endocytosis could be a viable strategy for the management of viral infections with no alternative treatment options, such as coronavirus disease 2019 (COVID-19)."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T14","span":{"begin":20,"end":45},"obj":"http://purl.obolibrary.org/obo/GO_0045806"},{"id":"T15","span":{"begin":34,"end":45},"obj":"http://purl.obolibrary.org/obo/GO_0006897"},{"id":"T16","span":{"begin":95,"end":111},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"However, short-term inhibition of endocytosis could be a viable strategy for the management of viral infections with no alternative treatment options, such as coronavirus disease 2019 (COVID-19)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T31","span":{"begin":0,"end":195},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, short-term inhibition of endocytosis could be a viable strategy for the management of viral infections with no alternative treatment options, such as coronavirus disease 2019 (COVID-19)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"126","span":{"begin":95,"end":111},"obj":"Disease"},{"id":"127","span":{"begin":159,"end":183},"obj":"Disease"},{"id":"128","span":{"begin":185,"end":193},"obj":"Disease"}],"attributes":[{"id":"A126","pred":"tao:has_database_id","subj":"126","obj":"MESH:D001102"},{"id":"A127","pred":"tao:has_database_id","subj":"127","obj":"MESH:C000657245"},{"id":"A128","pred":"tao:has_database_id","subj":"128","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, short-term inhibition of endocytosis could be a viable strategy for the management of viral infections with no alternative treatment options, such as coronavirus disease 2019 (COVID-19)."}